NEXT STAGE～ Future of Medicine and Community
During this unprecedented crisis caused by the COVID-19 pandemic, I feel sincere compassion for all of you who are working hard on the front lines of health care, striving to bring this situation to a resolution as quickly as possible.
My name is Yoshihiko Saito, and I work in the Department of Cardiovascular Medicine at the Nara Medical University. I am extremely honored to have been assigned to chair the 85th Annual Scientific Meeting. Together with all hospital staff, we are doing our best preparing for the success of the meeting.
The 85th Annual Scientific Meeting of the Japanese Circulation Society will be held at PACIFICO Yokohama on March 26–28, 2021. It will be held in conjunction with the World Congress of Cardiology (WCC). With our Japanese Circulation Society (JCS) currently promoting greater internationalization, I see it as immensely significant that the 85th Annual Scientific Meeting and the WCC are to be held jointly.
Coinciding with the start of the new Reiwa era in Japan, cardiology is entering a time of great change, as is medicine and society in general. In medical research, there has been remarkable innovation, including in iPS cells, genome editing, whole genome sequencing, RNA sequencing, big data and artificial intelligence. Research methods used in cardiovascular medicine and surgery have also changed dramatically. In addition, on the front line of cardiovascular medicine, latest technologies such as TAVI, catheter intervention and ablation, and implantable devices have been applied in the clinical setting, and cardiac regenerative medicine too has all but progressed to actual clinical practice.
In this context, it is time to reconsider the essential roles of the JCS in cardiovascular medicine and medical care, and in society, based on reverence for life and compassion for those suffering from cardiovascular disease.
Based on these viewpoints, the theme for the meeting has been set as “NEXT STAGE: Future of Medicine and Community.” Moreover, rather than the usual exhibition limited to pharmaceutical companies and medical device manufacturers, a special exhibition “Future of Medicine and Community: Future HealthTech for Life” has been planned. More suited to this time of great change for cardiovascular medicine, the exhibition will be open to everyone from a wide range of industries.
Success of the meeting can only be achieved with everyone’s support and cooperation. I look forward to seeing you in Yokohama in March 2021.